Evidence map›Paper›PMID 37631037›Full record

ReviewPharmaceuticals (Basel, Switzerland)2023

Natural Products Treat Colorectal Cancer by Regulating miRNA.

Shuoxi Guo, Meiqi Chen, Shuangyang Li, Zijun Geng, Ye Jin, Da Liu

Open access · goldAbstract readReview
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. The Role of Tumor Stem Cells in Colorectal Cancer Drug Resistance.Cancer control : journal of the Moffitt Cancer Center
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Shuoxi GuoSchool of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China.
Meiqi ChenSchool of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China.
Shuangyang LiSchool of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China.
Zijun GengSchool of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China.
Ye JinSchool of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China.
Da LiuSchool of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China.ORCID 0000-0003-0024-6329
Changchun University of Chinese Medicine · CN

Funding

China Postdoctoral Science Foundation 2020M670825 and 2020T130568Jilin Province Science and Technology Development Project in China 20210204013YY, and 20230401062YYNational College Students' innovation and entrepreneurship training program 202210199004 and 202210199011XNational Natural Science Foundation of China 82003985
6 · The paper itself

Abstract

Diseases are evolving as living standards continue to improve. Cancer is the main cause of death and a major public health problem that seriously threatens human life. Colorectal cancer is one of the top ten most common malignant tumors in China, ranking second after gastric cancer among gastrointestinal malignant tumors, and its incidence rate is increasing dramatically each year due to changes in the dietary habits and lifestyle of the world's population. Although conventional therapies, such as surgery, chemotherapy, and radiotherapy, have profoundly impacted the treatment of colorectal cancer (CRC), drug resistance and toxicity remain substantial challenges. Natural products, such as dietary therapeutic agents, are considered the safest alternative for treating CRC. In addition, there is substantial evidence that natural products can induce apoptosis, inhibit cell cycle arrest, and reduce the invasion and migration of colon cancer cells by targeting and regulating the expression and function of miRNAs. Here, we summarize the recent research findings on the miRNA-regulation-based antitumor mechanisms of various active ingredients in natural products, highlighting how natural products target miRNA regulation in colon cancer prevention and treatment. The application of natural drug delivery systems and predictive disease biomarkers in cancer prevention and treatment is also discussed. Such approaches will contribute to the discovery of new regulatory mechanisms associated with disease pathways and provide a new theoretical basis for developing novel colon cancer drugs and compounds and identifying new therapeutic targets.

Indexed as

colorectal cancercurcuminepigenetic: non-coding RNAgrape seednatural product

Identifiers

PMID37631037
PMCPMC10459054
OpenAlexW4385708746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.